Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
08/2003
08/21/2003WO2003068751A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders
08/21/2003WO2003068732A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158177 Treating or preventing obesity
08/21/2003US20030158176 Quaternary ammonium compounds
08/21/2003US20030155299 Caprolactam from aminocapronitrile; extraction, distillation
08/21/2003CA2475783A1 Benzenesulfonamide derivatives as antipsychotic agents
08/20/2003EP1335988A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
08/20/2003EP1335915A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/20/2003EP1335904A2 Production of alkyl 6-aminocaproate
08/20/2003EP1335897A1 Production of 6-aminocaproic acid
08/20/2003CN1437582A Method for purifying lactams
08/14/2003WO2003066597A2 Guanidino compounds
08/14/2003WO2002020475A3 Inhibitors of serine protease activity of matriptase or mtsp1
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/14/2003US20030153749 Method for the production of caprolactam
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003CN1436175A Cyclic lactams as inhibitors of A beta-protein production
08/13/2003CN1436171A Method for production of caprolactam
08/13/2003CN1435412A Process for preparing epsilon-caprolactam
08/13/2003CN1117569C Bicyclic fibrinogen antagonists
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/07/2003US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332129A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003CN1434803A Cyclic lactams as inhibitors os A-alpha protein production
08/05/2003CA2077708C Cyclic nitrones
07/2003
07/31/2003WO2003062224A1 Aza-cyclic compounds as modulators of acetylcholine receptors
07/31/2003WO2003062205A1 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
07/31/2003WO2003061662A1 Orodispersible pharmaceutical composition comprising ivabradine
07/31/2003WO2002040471A9 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
07/31/2003US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists
07/31/2003US20030144175 Protease inhibitors
07/30/2003EP1330464A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
07/30/2003EP1011679B1 Use of 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
07/30/2003CN1433402A Cycloamine CCR5 receptor antagonists
07/29/2003US6599898 Use of certain substituted caprolactam carbonates and ethers in treating tumors
07/24/2003WO2003059939A1 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
07/24/2003WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction
07/24/2003CA2473447A1 Solid salts of benzazepine compounds and their use in the preparation of pharmaceutical compounds
07/23/2003CN1431993A Method for separating ammonia from solutions contg. caprolactam and ammonia
07/23/2003CN1431904A Protease inhitors
07/22/2003US6596862 Purification of N-vinyl-ε-caprolactam
07/17/2003WO2003057254A1 Preventives/remedies for urinary disturbance
07/17/2003US20030134842 Method of treating or preventing an inflammatory disease, said method comprising the step of administering to a subject suffering from an inflammatory disease a therapeutically effective amount of a compound having the formula:
07/17/2003US20030134841 Succinoylamino lactams as inhibitors of A-beta protein production
07/17/2003US20030132098 Distilling of mixture at an absolute pressure of less than 10 bar
07/17/2003CA2471760A1 Preventives/remedies for urinary disturbance
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1114403C Vitronectin receptor antagonists
07/15/2003US6593474 Adrenergic blocking agents
07/15/2003US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
07/15/2003US6593322 Compounds and methods for modulation of estrogen receptors
07/10/2003WO2003032908A3 Novel prodrugs of n-h bond-containing compounds and methods of making thereof
07/10/2003US20030130256 Stimulant of central nervous system regeneration
07/10/2003US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/10/2003US20030130125 Pesticides; herbicides
07/09/2003EP1325054A1 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers
07/09/2003CN1429213A Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
07/08/2003US6590115 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds
07/03/2003WO2003053936A1 Dopamine d1 receptor agonist pro-drug compounds & derivatives
07/03/2003WO2003053935A1 Method for preparing lactam
07/03/2003US20030125546 Method for producing caprolactam from 6-aminocapronitrile
07/03/2003US20030125317 Vitronectin receptor antagonists
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1322617A1 Compounds and methods for modulation of estrogen receptors
07/02/2003EP1322609A2 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
07/02/2003CN1427822A Method for producing caprolactam from 6-aminocapronitrile
07/02/2003CN1427821A Method for producing cyclic lactams
07/02/2003CN1427820A Method for producing caprolactam from 6-aminocapronitrile and crystalline purifying
07/02/2003CN1427819A Method for producing cyclic lactams
06/2003
06/26/2003US20030120115 Supported cobalt catalysts for nitrile hydrogenations
06/26/2003US20030119858 Conformationally constrained compounds as pharmaceutical agents
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119826 Neuroprotective treatment methods using selective iNOS inhibitors
06/26/2003US20030119815 Lactams substituted by cyclic succinates as inhibitors of A-beta protein production
06/26/2003US20030119814 Novel prodrugs of N-H bond-containing compounds and methods of making thereof
06/19/2003US20030114664 Method for producing cyclic lactams
06/19/2003US20030114438 Lactam derivatives as antiarrhythmic agents
06/19/2003US20030114437 Protease inhibitors
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/17/2003US6579979 Hydrogenating liquid medium of reaction in presence of hydrogenation catalyst, reaction medium having an effective lactam-purifying amount of ammonia dissolved therein
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579867 Azepin-2-one derivatives useful for treating Alzheimer's disease
06/12/2003WO2002047679A3 Nonpeptide agonists and antagonists of vasopressin receptors
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109522 Ophthalmologic treatment methods using selective iNOS inhibitors
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003CN1423636A Method for purifying lactames
06/10/2003US6576780 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
06/05/2003WO2003045913A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use
06/05/2003WO2003045911A1 Process for recovering caprolactam
06/05/2003WO2003045909A2 Methods and intermediates for the synthesis of azepines
06/05/2003US20030105322 Catalytically reacting 6-aminocapronitrile and water in the gas phase, removing ammonia from the resulting mixture of caprolactam, water, high-and low-boiling components, then removing water, then crystallization
06/05/2003US20030105099 Novel compounds and compositions as cathepsin inhibitors
06/05/2003US20030105076 Reacting 10-methoxyiminostilbene with cyanic acid (HOCN) in a solvent therefor in the presence of a mild acidic reagent to produce 10-methoxycarbamazepine
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 88